Technology
Health
Biotechnology

MeiraGTx

$27.00
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$0.02 (-0.07%) Today
$0.00 (0.00%) As of 4:00 PM EDT after-hours

Why Robinhood?

You can buy or sell MeiraGTx and other stocks, options, ETFs, and crypto commission-free!

About MGTX

MeiraGTx Holdings plc Ordinary Shares, also called MeiraGTx, is a clinical-stage biotech company, which engages in the development of novel gene therapy treatments. It operates through the United States and United Kingdom geographical segments. Read More Its pipeline includes AAV-CNGB3, AAV-CNGA3, AAV-RPE65, AAV-RPGR, AAV-AQP1, and AAV-UPF1. The company was founded on March 20, 2015 and is headquartered in New York, NY.

Employees
68
Headquarters
New York, New York
Founded
2015
Market Cap
900.92M
Price-Earnings Ratio
Dividend Yield
Average Volume
128.35K
High Today
$27.18
Low Today
$26.24
Open Price
$27.02
Volume
116.89K
52 Week High
$30.23
52 Week Low
$7.98

Collections

Technology
Health
Biotechnology
Medical
Therapy
2018 IPO
US
North America

MGTX Earnings

-$2.29
-$1.72
-$1.15
-$0.58
Q2 2018
Q3 2018
Q4 2018
Q1 2019
Q2 2019
Estimated
Actual
Expected Aug 7, Pre-Market
All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Securities offered through Robinhood Financial LLC, member FINRA/SIPC. To learn more about the information provided on this page, please see our Web Disclosures.